Term
Native Valve Highly Susceptible to PCN MIC ≤ 0.12μg/mL
Viradans Gr Strept & S. bovis
4wk OR 2wk (uncomplicated) w/ gent 2wk |
|
Definition
PCN G 12-18million U/Q24H IV continuously or 4-6 DD X 4 wks OR Ceftriaxone 2g IV X 1dose x 4 wks
PCN G 12-18 million U/Q24H IV continuously or 6 DD x 2 wks OR Ceftriaxone 2g IV X 1 dose x 2 wks
PLUS Gent 3mg/kg X 1 dose X 2 wks
|
|
|
Term
Native valve Relatively resistant PCN MIC >0.12 ug/mL ≤0.5 ug/mL Viridans Gr Strept & S. bovis
4wk + 2wk Gent |
|
Definition
PCN G 24 million U/Q24H continuously or 4-6 DD X 4 wks
OR Ceftriaxone 2g IV X 1 dose X 4 wks
PLUS Gentamicin 3mg/kg IV Q24H X 1 dose X 2wks
Vancomycin 30mg/kg / Q24H IV x 2DD X 4wks |
|
|
Term
Prosthetic valve Staphylococcus Oxacillin susceptible
same as above Oxacillin resistant
both 3 drug ≥ 6 wks
|
|
Definition
Nafcillin or Oxacillin 12g IV x 6 DD ≥ 6 wks PLUS Rifampin 900mg IV x 3 DD ≥ 6 wks PLUS Gentamicin IV x 2-3 DD X 2 wks
Vancomycin 30mg/kg IV x 2 DD ≥ 6 wks PLUS rifampin 900mg IV x 3 DD ≥ 6 wks PLUS Gentamicin 3mg/kg IV x 2-3 DD x 2 wks |
|
|
Term
Prosthetic or Native valve PCN susceptible MIC ≤0.12ug/mL Viridans Gr Strept & S. bovis
6 wk & 2 wk Gent
(same as above but)
PCN susceptible MIC >0.12ug/mL
6 wk all
|
|
Definition
PCN G 24 million IV Q24H continuously OR 4-6 DD X 6 wks OR Ceftriaxone 2g X 1 dose X 6 wks
w or w/o Gent 3mg/kg x 1 dose X 2wks OR
Vancomycin 30mg/kg X 2 DD X 6wks
PCN G 24 million IV Q24H continuously OR 4-6 DD X 6 wks OR Ceftriaxone 2g IV X 1 dose X 6 wks
PLUS
Gentamicin 3mg/kg x 1 dose X 6 wks OR Vanc same as above
|
|
|
Term
Native Staphylococcus Oxacillin susceptible
6wk + 3-5 days Gent
same as above
Oxacillin resistant
|
|
Definition
Oxacillin susceptible
Naficillin or oxacilllin 12g IV 4-6 DD x 6 wks w/ Gent 3mg/kg X 2-3 DD x 3-5days IF PCN ALL. Cefazoline 6g x 2-3 DD X 6 wks w/ Gent 3mg/kg X 2-3 DD X 3-5 days
oxacilllin resistant
Vancomycin 30mg/kg IV X 2 DD X 6 wks |
|
|